Caitong International Asset Management Co., LTD Moon Lake Immunotherapeutics Transaction History
Caitong International Asset Management Co., LTD
- $140 Billion
- Q2 2025
A detailed history of Caitong International Asset Management Co., LTD transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Caitong International Asset Management Co., LTD holds 376 shares of MLTX stock, worth $3,444. This represents 0.01% of its overall portfolio holdings.
Number of Shares
376
Previous 147
155.78%
Holding current value
$3,444
Previous $5.74 Million
209.02%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MLTX
# of Institutions
157Shares Held
54.5MCall Options Held
799KPut Options Held
661K-
Bvf Inc San Francisco, CA19.8MShares$181 Million36.63% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$77.8 Million40.43% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.15MShares$38 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.61MShares$23.9 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.67MShares$15.3 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $338M
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...